We hypothesized that the favorable treatment outcome in our patient might be attributed to the fact that both the PNS-encephalitis and the tumor were in the very early stages, and the FcRn inhibitor effectively reduced the pathogenic KLHL11 IgG level and alleviated autoreactive T cell activation and the production of systemic pro-inflammatory cytokines. This evidence concerns the gene FCGRT and encephalitis.